A carregar...
Long-term response rates to infliximab therapy for Crohn’s disease in an outpatient cohort
BACKGROUND: Infliximab’s efficacy in the induction and maintenance of remission in luminal Crohn’s disease has been confirmed by randomized, controlled trials. Less clearly described are long-term outcomes in the clinical practice setting since the establishment of regularly scheduled, every eight-w...
Na minha lista:
| Main Authors: | , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Pulsus Group Inc
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2706747/ https://ncbi.nlm.nih.gov/pubmed/19440565 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|